Novavax, Inc.’s outlook improves with a Sanofi partnership and upgraded 2025 revenue guidance. Click here to find out why ...

Lupus nephritis occurs in approximately half of patients diagnosed with systemic lupus erythematosus. One in 10 patients with ...

Reagents are expected to dominate with 27.2% market share in 2025, thanks to their essential role in protein expression ...

A team from the University of Illinois has uncovered surprising evolutionary links between the genetic code and tiny protein ...

ON THIS PAGEWhat It IsWho Should Get ItWho Shouldnt Get ItWhen to Get ItEffectivenessSee more (4) A typical U.S. flu season sickens millions of people, sends hundreds of thousands to the hospital, and ...

Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...

LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR) technology has been approved for evaluation in the clinic by ...

Respiratory illness season generally runs from November to March. It can take two weeks to build immunity after receiving ...

Beta-lactoglobulin, the most abundant whey protein in dairy, outperforms other forms of whey and casein—precision ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

The VTT Technical Research Centre of Finland has challenged a key patent filed by The Every Company at the European Patent ...